Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study(legacy) | 143 |
| Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study(legacy) | 110 |
Total Visits per Month
| October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
|---|---|---|---|---|---|---|---|
| Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study | 2 | 4 | 0 | 3 | 0 | 6 | 5 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| Australia | 106 |
| United States | 63 |
| China | 15 |
| France | 13 |
| Netherlands | 8 |
| Vietnam | 8 |
| United Kingdom | 5 |
| Germany | 4 |
| Italy | 3 |
| Argentina | 2 |
Top City Views
| Views | |
|---|---|
| Kaleen | 50 |
| Ashburn | 21 |
| Fairfield | 8 |
| Hanoi | 8 |
| Rotterdam | 8 |
| Dearborn | 4 |
| Nanjing | 3 |
| Sydney | 3 |
| Adelaide | 2 |
| Cambridge | 2 |